© Genesis Research Services, 2023
Menu
In this issue, we introduce you to our newest team member and talk about conferences, training workshops, quality, and mental health first aid. We have started recruiting participants for a new migraine clinical trial and proudly performed the world’s first implant for a clinical trial involving a new spinal cord stimulator device.
Do you suffer from chronic migraines? We are running a study for a new implantable medical device used as an alternative treatment for chronic migraines. The device is designed to provide mild electrical stimulation to the nerves associated with migraines in order to reduce the number and pain intensity of the migraines you experience.
View our trials page for more information.
Do you suffer from depressive symptoms? We are currently recruiting participants for a new clinical trial for people living with Depression / Major Depressive Disorder. The trial involves an investigational drug that aims to improve the cognitive symptoms associated with depression, such as memory loss, and difficulty thinking and making decisions.
View our trials page for more information.
Knee osteoarthritis is characterised by bone changes, progressive loss of cartilage, joint space narrowing, and even total joint failure. It causes pain, physical disability, and reduced quality of life. Current treatments include medications, creams, gels, and injections.
We frequently conduct trials involving treatments for osteoarthritis of the knee. Treatments may include oral medications, topical treatments, or injections.
To register your interest for future studies, visit our trials page.
Low back pain is one of the most common types of pain reported by patients and the leading cause of disability worldwide.
We conduct numerous trials for people living with low back pain. Trials may involve injections or medical devices such as spinal cord stimulators. Medical costs are typically covered (no private health insurance is required).
To register your interest for future studies, visit our trials page.
We are excited to introduce you to Sam, our Business Development Manager. Sam has a Nuclear Medicine degree from the University of Newcastle and is currently completing an MBA/Master of Health Management, Policy and Economics.
Sam is passionate about improving the health outcomes and quality of life of participants through ethical research and clinical trials. She has a special interest in enabling access to clinical trials to all people and ensuring that we embed a culture of inclusion, diversity and equity within our conduct of clinical trials.
We are proud to announce that Genesis staff are accredited Mental Health First Aiders. This means that we are equipped with the skills, knowledge, and confidence to understand and provide basic support to people experiencing a mental health problem or crisis.
Our training is provided by Mental Health First Aid Australia. We highly recommend their courses to all who are interested!
Last month, Emily and Sam attended the 2023 ARCS Annual Conference in Sydney. This year’s theme was “Building our sector for better patient outcomes”.
The take home messages from ARCS were the importance of participant communication and emphasising meaningful and relevant engagement to participants from all backgrounds and communities; and, how important the ever-changing role of information technology and the use of media platforms are within in an ever-evolving research landscape.
Bethany recently attended a venous blood collection training workshop to gain the knowledge and skills to safely obtain blood samples. We have been volunteering our veins for practice and can say that Bethany does an amazing job! We are so proud of her.
All our clinical trial coordinators are now trained in venipuncture.
It was a great privilege for our team to perform the world’s first permanent implant of a new spinal cord stimulator device. The device delivers ultra-low frequency electrical current to the spinal cord with the aim to provide relief of chronic low back and/or leg pain.
We previously conducted clinical trials involving a temporary trial version of the device and are excited to see participants progressing through to implant.
Genesis Research Services implements a Quality Management System (QMS) that complies with the International Quality Management Standard ISO AS/NZS 9001:2016.
To maintain ISO 9001 certification, our QMS is subject to annual external audits. We passed our audit in May. Amy and Emily did an amazing job preparing for the audit and have made major improvements to our QMS.
Spinal cord stimulation (SCS) is an advanced treatment option for chronic pain. It is most commonly used to treat chronic low back and leg pain. SCS has been around since the 1960s and has evolved greatly over the years.
In this article, we provide a brief history of SCS and review some of the most significant updates to SCS technology that are in use today.
View our currently recruiting studies:
Register your interest for future studies:
© Genesis Research Services, 2023